Onconetix to Acquire Realbotix LLC in All-Stock Share Exchange

February 12, 2026

Onconetix, Inc. (Nasdaq: ONCO) signed a definitive share exchange agreement to acquire 100% of the issued and outstanding equity interests of Realbotix LLC in an all-stock transaction. The deal is expected to close in the second half of 2026, subject to customary approvals including Onconetix shareholder approval and regulatory clearances.

Buyers
Onconetix, Inc.
Targets
Realbotix LLC, Realbotix Corp. (Realbotix Parent, referenced as owner of Realbotix LLC)
Sellers
Realbotix Corp. (Realbotix Parent, as the parent of Realbotix LLC; equity interests referenced as being acquired)
Location
Nevada, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.